Notification That Annual Report Will Be Submitted Late (nt 10-k)
06 April 2018 - 11:08AM
Edgar (US Regulatory)
|
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
one):
|
OMB
APPROVAL
|
|
OMB
Number: 3235-0058
Expires: October 31, 2018
Estimated average burden
hours per response.... 2.50
|
|
|
|
SEC
FILE NUMBER
000-28911
|
|
|
|
CUSIP
NUMBER
137648101
|
[
X ] Form 10-K
[ ] Form 20-F
[ ] Form 11-K
[ ] Form 10-Q [ ]
Form 10-D [ ] Form N-SAR
[ ] Form N-CSR
For
Period Ended:
December 31, 2017
[ ]
|
Transition Report
on Form 10-K
|
[ ]
|
Transition Report
on Form 20-F
|
[ ]
|
Transition Report
on Form 11-K
|
[ ]
|
Transition Report
on Form 10-Q
|
[ ]
|
Transition Report
on Form N-SAR
|
For
the Transition Period Ended:
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
|
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
CANNABIS
SCIENCE INC.
Full Name of Registrant
N/A
Former Name if Applicable
19800
MacArthur Blvd., Suite #300
Address of Principal Executive Office
(Street and Number)
Irvine,
California 92612
City, State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate)
x
|
(a)
|
The
reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
|
|
(b)
|
The subject annual
report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof,
will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or
transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date; and
|
|
|
(c)
|
The accountant's statement
or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof,
could not be filed within the prescribed time period.
The
Registrant is unable to file, without unreasonable effort and expense, its Form 10-K Annual Report for the year ended December
31, 2017, in a timely manner because of unanticipated delays, It is anticipated that the Form 10-K Annual Report, along with the
audited financial statements, will be filed on or before the 15th calendar day following the prescribed due date of the Registrant's
Form 10-K.
PART
IV — OTHER INFORMATION
(1)
|
Name and telephone
number of person to contact in regard to this notification
|
|
Raymond
C. Dabney
|
(888)
|
263-0832
|
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of
the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed ? If answer is no, identify report(s).
[
X ] Yes [ ] No
|
|
|
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be included in the subject report or portion thereof?
[ ]
Yes [ X ] No
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
|
CANNABIS
SCIENCE, INC.
(Name of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date:
April 5, 2018
|
By:
|
/s/
Raymond C. Dabney
|
|
|
Raymond C. Dabney
|
|
Title:
|
President and Chief
Executive Officer
|